Skip to main content
S&P 5007,663.43-1.21%DOW52,867.98+0.02%NASDAQ26,008.86-2.60%BTC$81,395.00-3.35%ETH$2,391.93-3.37%GOLD$4,036.20-0.60%OIL$99.27-0.20%
Smart Investors Daily
SID Premium
Tenon Medical, Inc. logo

NASDAQ · TNON

Tenon Medical, Inc.

Healthcare · Medical - Devices

$2.24

Down-$0.27 (-10.76%)

Updated Oct 23, 2026, 5:50 AM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
9.87M
P/E ratio
-0.74
Dividend yield
0.00%
52-week range
$0.18 – $17.84
Volume
112.24K
Avg. volume
419.87K

Price performance · TNON

TNON price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 22, 2026

TNON closed at $2.24 after 21 trading sessions, down 24.32% for the selected period.

Last close
$2.24
Period change
-24.32%
Period low
$2.24
Period high
$4.09
Daily close
View OHLC price history
TNON OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 22, 2026$2.45$2.479$2.225$2.24112.24K
Oct 21, 2026$2.47$2.59$2.42$2.5186.73K
Oct 20, 2026$2.46$2.54$2.42$2.5183.98K
Oct 19, 2026$2.58$2.615$2.43$2.45158.65K
Oct 16, 2026$2.95$3.06$2.67$2.70217.89K
Oct 15, 2026$2.83$2.93$2.78$2.91150.04K
Oct 14, 2026$2.82$2.94$2.80$2.82158.57K
Oct 13, 2026$2.98$3.10$2.85$2.89228.54K
Oct 12, 2026$3.34$3.36$2.9501$2.98264.34K
Oct 9, 2026$3.41$3.52$3.37$3.41133.89K
Oct 8, 2026$3.46$3.5779$3.42$3.44115.54K
Oct 7, 2026$3.58$3.64$3.38$3.50356.19K
Oct 6, 2026$3.80$3.82$3.62$3.715428.81K
Oct 5, 2026$3.55$3.82$3.52$3.70463.62K
Oct 2, 2026$4.50$4.65$3.65$3.705.89M
Oct 1, 2026$3.945$4.18$3.6501$4.042.09M
Sep 30, 2026$2.80$5.04$2.75$4.0953.28M
Sep 29, 2026$2.80$2.8793$2.67$2.73283.56K
Sep 28, 2026$3.025$3.05$2.86$2.86198.38K
Sep 25, 2026$2.95$3.18$2.94$3.131.74M
Sep 24, 2026$3.18$3.2648$2.95$2.96364.32K

Latest TNON news

The latest Smart Investors Daily articles mentioning TNON.

Stock researchCompany · Overview

TNON research

Overview

Company profile and research snapshot.

Company profile

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
TNON recent ratings
DateFirmRatingTarget
Apr 9, 2025Alliance Global PartnersBuy—
Nov 15, 2024Maxim GroupBuy—
Aug 14, 2024BenchmarkSpeculative Buy—
Apr 15, 2024BenchmarkSpeculative Buy—
Mar 10, 2023BenchmarkBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 15, 2026

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~~Portfolio now includes 38 issued U. patents and 9 international patents, with 31 applications pending~~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / , Inc.

Yahoo · Sep 30, 2026

Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch

~ SImmetry+ System generated approximately $1.2 million in incremental revenue during limited launch period ~~ Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed ~~ New SImmetry+ 3D printed screw is the first component of a next-generation lateral SI joint fusion system, and the first of several Company product launches expected in the coming quarters ~LOS GATOS, CA / ACCESS Newswire / September 30, 2026 / , Inc.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By